Mark Sibbering
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Breast Lesions and Carcinomas
Papers in
-
- Breast Cancer Treatment Studies 12
-
- Breast Lesions and Carcinomas 10
- Co-authors
- Kieran Horgan (5 shared papers)Amit Goyal (2 shared papers)Robert G. Newcombe (2 shared papers)Robert E. Mansel (2 shared papers)Ian Monypenny (1 shared paper)Anne Fleissig (1 shared paper)David England (1 shared paper)Mark Kissin (1 shared paper)
- Journals
- European Journal of Surgical Oncology (4 papers)Health Technology Assessment (1 paper)BMJ Open (1 paper)Radiology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United KingdomUnited StatesTaiwan
In The Last Decade
Mark Sibbering
17 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Cancer Research 1.4k
- Pathology and Forensic Medicine 1.0k
- Oncology 713
- Surgery 758
- Dermatology 112
Countries citing papers authored by Mark Sibbering
This map shows the geographic impact of Mark Sibbering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sibbering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sibbering more than expected).
Fields of papers citing papers by Mark Sibbering
This network shows the impact of papers produced by Mark Sibbering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sibbering. The network helps show where Mark Sibbering may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Sibbering, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial Hit paper breakdown → | 2006 | 1225 |
| 2 | 2020 | 147 | |
| 3 | 1994 | 103 | |
| 4 | 2018 | 66 | |
| 5 | High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. | 1996 | 63 |
| 6 | 2004 | 51 | |
| 7 | 1994 | 42 | |
| 8 | 2013 | 39 | |
| 9 | 2018 | 15 | |
| 10 | 2013 | 12 | |
| 11 | 2016 | 12 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 1996 | 1 | |
| 16 | 1993 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2024 | 0 |
About Mark Sibbering
Mark Sibbering is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Surgery and Genetics, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (10 papers), Global Cancer Incidence and Screening (8 papers), Breast Implant and Reconstruction (4 papers), Cancer and Skin Lesions (3 papers), Advanced Breast Cancer Therapies (2 papers), BRCA gene mutations in cancer (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pathology and Forensic Medicine (1.0k citations), Oncology (713 citations), Surgery (758 citations) and Dermatology (112 citations). Mark Sibbering has collaborated with scholars based in United Kingdom, United States and Taiwan. Frequent co-authors include Kieran Horgan, Amit Goyal, Robert G. Newcombe, Robert E. Mansel, Ian Monypenny, Anne Fleissig, David England, Mark Kissin, Dayalan Clarke and Peter J. Ell. Their work appears in journals such as European Journal of Surgical Oncology, Health Technology Assessment, BMJ Open, Radiology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.